Spark Biomedical, Inc enlists the expertise of former Deputy Secretary of the U.S. Department of Health and Human Services, Eric D. Hargan, to help make novel opioid withdrawal treatment more accessible and affordable for patients
November 04, 2021 10:25 ET
|
Spark Biomedical
Dallas, TX, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc, a leader in wearable neurostimulation for opioid withdrawal relief, today announced the Company will join forces with Eric D....
PathMaker Neurosystems Appoints Leading Neurotechnology Expert, John Donoghue, Ph.D., to Board of Directors
October 21, 2021 05:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
The Worldwide Neurostimulation Devices Industry is Expected to Reach $12.7+ Billion by 2026
September 06, 2021 09:43 ET
|
Research and Markets
Dublin, Sept. 06, 2021 (GLOBE NEWSWIRE) -- The "Neurostimulation Devices Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The neurostimulation...
Global Neurostimulation Technologies Market Report 2021: Market Expected to Reach $9.8 Billion by 2026 from $7.1 Billion in 2021, at a CAGR of 6.9%
May 21, 2021 08:18 ET
|
Research and Markets
Dublin, May 21, 2021 (GLOBE NEWSWIRE) -- The "Global Neurostimulation Technologies Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global neurostimulation devices...
Global Neuroprotection Markets Report 2021: Focus on Agents, Cerebrovascular Disease, Traumatic Brain & Spinal Injury, Parkinson's, Alzheimer's, Huntington's, ALS, Optic Nerve and the Retina
May 12, 2021 04:28 ET
|
Research and Markets
Dublin, May 12, 2021 (GLOBE NEWSWIRE) -- The "Neuroprotection - Methods, Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report...
Outlook on the Neuroprosthetics Global Market to 2029 - Featuring Abbott Laboratories, Boston Scientific and Cochlear Limited Among Others
May 10, 2021 06:23 ET
|
Research and Markets
Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "Neuroprosthetics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,...
BlueWind Medical Strengthens Board of Directors with appointment of Kerry Nelson
December 22, 2020 12:49 ET
|
BlueWind Medical
PARK CITY, Utah and BOSTON, Dec. 22, 2020 (GLOBE NEWSWIRE) -- BlueWind Medical, a medical device company developing minimally invasive neurostimulation devices, announced today the appointment of...
Global Neuroprotection Markets Report 2020: Focus on Cerebrovascular Disease, Traumatic Brain & Spinal Cord Injury, Neurodegenerative, Parkinson's, Alzheimers, Huntington ALS, Optic Nerve and Retina
December 21, 2020 06:13 ET
|
Research and Markets
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "Neuroprotection - Methods, Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This...
Spark Biomedical Receives FDA Breakthrough Device Designation for Infant Transcutaneous Auricular Neurostimulation (tAN™) Device, The Roo™ System
December 15, 2020 14:14 ET
|
Spark Biomedical
Dallas, Texas, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc. announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Roo System: a...
Neurostimulation Devices Market To Reach USD 13.70 Billion by 2027 Growing at a CAGR of 12.6% | Emergen Research
December 02, 2020 09:53 ET
|
Emergen Research
Vancouver, British Columbia, Dec. 02, 2020 (GLOBE NEWSWIRE) -- The Global Neurostimulation Devices Market will be worth USD 13.70 Billion by 2027, according to the latest analysis by Emergen...